arrow
F

Fabio Giglio

Vita-Salute San Raffaele University
H指数:22
被引数:2,189

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Conditioning regimen for hematopoietic cell transplant in transfusion dependent thalassemia: Recommendations from the EBMT practice harmonisation and guidelines committee

输血依赖型地中海贫血造血细胞移植的预处理方案:EBMT实践协调与指南委员会的建议

2026-07-220
PRE
Favorable outcomes after early allogeneic stem cell transplantation in adult early T-cell precursor acute lymphoblastic leukemia treated with the pediatric-inspired GIMEMA LAL1913 program. A Campus ALL study

成人早期T细胞前体急性淋巴细胞白血病患者在接受儿科启发式GIMEMA LAL1913方案治疗后,早期同种异基因干细胞移植的积极结果。Campus ALL研究

2026-07-160
PRE
Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols
2026-07-080
OA
The Homozygous p.(Arg215Ter) Variant in XRCC2 Is Associated With Atypical Fanconi Anemia Without Major Hematological Abnormalities in Childhood

XRCC2基因同源p.(Arg215Ter)变异与无儿童期主要血液学异常的不典型范可尼贫血相关

2026-01-010
OAAI
Outcome of Adult Lymphoblastic Lymphoma Patients Treated in the Real Life According to the Gimema LAL1913 Protocol: A Campus ALL Multicenter Study
2025-11-120
PRE
Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT

维奈克拉 plus 低甲基化药物作为异基因HSCT后复发的髓系恶性肿瘤的首次挽救性治疗

2025-10-210
PRE
CC486 as a Safe and Effective Bridge to Transplant in MDS-del5q with Transfusion-Dependent Anemia Following Lenalidomide Relapse: A Case Report

CC486作为一种安全有效的移植桥梁,用于lenalidomide复发后的MDS-del5q伴输血依赖性贫血:一份病例报告

2025-07-090
PRE
Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/hypomethylating agents
2024-10-030
OAAI
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study
2024-08-152
OAAI
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study
2024-08-010
OAAI
Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort control
2024-05-231
OAAI
FLT3 alterations and inhibition in triple negative B-cell adult acute lymphoblastic leukemia patients
2024-03-220
PRE
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease
2023-12-074
OAAI
BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study
2023-10-051
OAAI
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients

异基因造血干细胞移植受者的人类疱疹病毒6特异性T细胞免疫

2023-09-1511
OAAI
Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft- versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases
2023-08-011
PRE
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia
2023-05-235
OAAI
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
2023-04-269
OAAI